Giri Devanur
CIK 1643490 · Executive Chairman · last filed 2026-05-04
Giri Devanur is an Executive Chairman who has filed 11 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for AIRE, was dated May 4, 2026. Across all open-market trades the lifetime net is −$838.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.42M
3
11
-$838.1K
Holdings By Company
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-04 | AIRE | Grant (A) | +13,323 | $0 | EDGAR |
| 2026-03-20 | BHAVU | Buy (P) | +270,000 | $0 | EDGAR |
| 2026-02-03 | AIRE | Grant (A) | +414,230 | $0 | EDGAR |
| 2025-11-03 | AIRE | — | — | $0 | EDGAR |
| 2025-11-03 | AIRE | Grant (A) | +149,133 | $0 | EDGAR |
| 2025-11-03 | AIRE | — | — | $0 | EDGAR |
| 2025-08-01 | AIRE | Grant (A) | +265,341 | $0 | EDGAR |
| 2025-05-01 | AIRE | Grant (A) | +178,596 | $0 | EDGAR |
| 2018-07-19 | Enveric Biosciences, Inc. (AMRHW) Delisted | Mixed | −429,357 | -$887.9K | EDGAR |
| 2017-11-21 | Enveric Biosciences, Inc. (AMRHW) Delisted | Buy (P) | +12,121 | $49.9K | EDGAR |